Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SANOFI | NSE
-17.70
-0.51%
Healthcare
Drug Manufacturers-General
30/06/2024
24/04/2026
3,427.60
3,481.00
3,481.00
3,419.00
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India Singapore and internationally. It provides pharmaceutical products in various therapeutic areas such as diabetes cardiology thrombosis central nervous system anti-infective epilepsy allergy and vitamins antihistamines and minerals and supplements under the Lantus Toujeo Clexane Amaryl Cardace Targocid Frisium Combiflam DePura Allegra and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
View LessLow 6-Month Volatility (<30%)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
15.7%1 month
23.1%3 months
22.4%6 months
19.4%29.45
-
23.14
0.03
0.02
20.28
5.66
-
7.78B
78.94B
822.67M
2.43
23.02
-16.00
-34.40
75.07
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
209.00
Range1M
449.00
Range3M
993.30
Rel. volume
0.45
Price X volume
72.12M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Marksans Pharma Limited | MARKSANS | Drug Manufacturers-General | 190.21 | 86.61B | -1.57% | 38.34 | 11.82% |
| Clean Science and Technology Ltd | CLEAN | Specialty Chemicals | 816.75 | 85.93B | 2.00% | 67.65 | 0.17% |
| Alkyl Amines Chemicals Limited | ALKYLAMINE | Specialty Chemicals | 1475.6 | 75.52B | -3.24% | 77.08 | 0.25% |
| Saregama India Limited | SAREGAMA | Entertainment | 346.75 | 68.14B | -0.47% | 54.06 | 0.37% |
| Galaxy Surfactants Limited | GALAXYSURF | Specialty Chemicals | 1764.5 | 62.71B | -2.02% | 34.36 | 8.60% |
| Sudarshan Chemical Industries Limited | SUDARSCHEM | Specialty Chemicals | 869.55 | 60.20B | -3.52% | 60.10 | 40.65% |
| Kingfa Science & Technology (India) Limited | KINGFA | Specialty Chemicals | 4920.4 | 59.59B | 0.06% | 30.96 | 5.53% |
| Gulf Oil Lubricants India Limited | GULFOILLUB | Specialty Chemicals | 969.5 | 48.26B | -0.26% | 19.73 | 28.21% |
| NEOGEN | NEOGEN | Specialty Chemicals | 1634.5 | 43.02B | -1.54% | 142.31 | 53.78% |
| Balaji Amines Limited | BALAMINES | Specialty Chemicals | 1250.6 | 41.02B | 0.86% | 36.10 | 1.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 50.36 | 44.18B | -2.59% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 105.44 | 15.54B | -1.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 261.58 | 15.33B | -2.64% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 89.31 | 1.30B | -1.13% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.31 | 839.62M | 0.39% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 20.28 | 25.64 | Cheaper |
| Ent. to Revenue | 5.66 | 6.59 | Par |
| PE Ratio | 29.45 | 41.48 | Cheaper |
| Price to Book | 23.14 | 10.46 | Expensive |
| Dividend Yield | 2.43 | 0.96 | Leader |
| Std. Deviation (3M) | 22.37 | 41.14 | Lower Risk |
| Debt to Equity | 0.03 | 0.14 | Cheaper |
| Debt to Assets | 0.02 | 0.08 | Cheaper |
| Market Cap | 78.94B | 186.70B | Emerging |